Cellular cardiomyoplasty for myocardial infarction: a 2014 evidence-based update

Alvin Nursalim, Puspita A. Katili, Teguh Santoso Sukamto

Research output: Contribution to journalReview articlepeer-review

Abstract

Myocardial infarction is one of the main cause of mortality in many countries. Therefore, an effective therapy for myocardial infarction is required. Reperfusion and other conventional therapy have been the mainstay therapy for myocardial infarction. However, many patients remain refractory to this therapy. Cellular cardiomyoplasty is considered a novel therapy, in which stem cells are used for cardiac repair. Stem cells are potential therapeutic approach that could be the ultimate solution for salvaging damaged cardiomyocyte. Based on current studies, stem cells are a promising therapeutic approach for myocardial infarction. However, some challenges need to be answered by future studies before this novel therapy can be widely applied. As we advance our understanding, all questions behind stem cell therapy would finally be revealed, and eventually provide the ultimate solution for ischaemic cardiac repair. This paper provide an overview of the latest progress in stem cell therapy for myocardial infarction.

Original languageEnglish
Pages (from-to)150-162
Number of pages13
JournalActa medica Indonesiana
Volume46
Issue number2
Publication statusPublished - 1 Apr 2014

Fingerprint Dive into the research topics of 'Cellular cardiomyoplasty for myocardial infarction: a 2014 evidence-based update'. Together they form a unique fingerprint.

Cite this